Chronic liver diseases such as hepatitis, liver cirrhosis, and hepatocellular carcinoma are a major cause of morbidity and mortality worldwide. Fibrosis—the thickening and scarring of connective ...

Quibim, a global company pioneering imaging biomarkers for precision medicine, is today announcing the launch of a new product, QP-Liver, which improves the diagnosis of diffuse liver diseases through ...

Please provide your email address to receive an email when new articles are posted on . Treatment responders demonstrated significant reductions in iron corrected T1 and liver fat content. Optimal ...

WASHINGTON & OXFORD, England--(BUSINESS WIRE)--Perspectum announced two research studies that were recently published, bringing hope to people with metabolic dysfunction-associated steatohepatitis ...

Dr. Jason Chiang and Dr. Kyung Sung of the department of radiological sciences at the David Geffen School of Medicine at UCLA and the UCLA Health Jonsson Comprehensive Cancer Center have received a $3 ...

BodyView Preventive MRI provides patients with a smooth, professional — and perhaps even lifesaving — experience.

Non-contrast MRI as a surveillance tool for recurrent hepatocellular carcinoma after curative treatment: A prospective multicenter intra-individual comparison trial. First line atezolizumab + ...

Add Yahoo as a preferred source to see more of our stories on Google. We spoke with three major companies that offer such testing – Function (which recently acquired Ezra), Prenuvo and SimonMed – and ...

SAN ANTONIO, Texas (Ivanhoe Newswire) – Each year, 40 million Americans undergo an MRI scan, or magnetic resonance imaging. It’s the best way for physicians to glimpse inside the body without surgery.

A single enzyme inside liver cells drives the production of triglycerides that, in excess, fuel the inflammation and scarring ...